Buscar
01/08/2021
Late onset Sandhoff disease presenting with lower motor neuron disease and stuttering
Alonso-Perez, J, Casasus, A, Gimenez-Munoz, A, Duff, J, Rojas-Garcia, R, Illa, I, Straub, V, Topf, A, Diaz-Manera, J. Late onset Sandhoff disease presenting with lower motor neuron disease and stuttering. NEUROMUSCULAR DISORDERS. 2021; 31(8)DOI:10.1016/j.nmd.2021.04.011. PMID:34210542. IF:3.538(Q2/5D).
29/07/2021
Quantifying the patient ' s perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire
Meca-Lallana, JE, Maurino, J, Perez-Miralles, F, Forero, L, Sepulveda, M, Calles, C, Martinez-Gines, ML, Gonzalez-Suarez, I, Boyero, S, Romero-Pinel, L, Sempere, AP, Meca-Lallana, V, Querol, L, Costa-Frossard, L, Prefasi, D, Gomez-Ballesteros, R, Ballesteros, J. Quantifying the patient ' s perspective in neuromyelitis optica spectrum disorder: Psychometric properties of the SymptoMScreen questionnaire. PLoS One. 2021; 16(7)DOI:10.1371/journal.pone.0255317. PMID:34324586. IF:3.752(Q2/4D).
13/07/2021
Magnetization Transfer Ratio in Lower Limbs of Late Onset Pompe Patients Correlates With Intramuscular Fat Fraction and Muscle Function Tests (vol 12, 634766, 2021)
Nunez-Peralta, C, Montesinos, P, Alonso-Jimenez, A, Alonso-Perez, J, Reyes-Leiva, D, Sanchez-Gonzalez, J, Llauger-Rosello, J, Segovia, S, Belmonte, I, Pedrosa, I, Martinez-Noguera, A, Matellini-Mosca, B, Walter, G, Diaz-Manera, J. Magnetization Transfer Ratio in Lower Limbs of Late Onset Pompe Patients Correlates With Intramuscular Fat Fraction and Muscle Function Tests (vol 12, 634766, 2021). Frontiers in Neurology. 2021; 12DOI:10.3389/fneur.2021.727020. PMID:34326809. IF:4.086(Q2/5D).
03/07/2021
Outcome measures and biomarkers in chronic inflammatory demyelinating polyradiculoneuropathy: from research to clinical practice
Allen, JA, Eftimov, F, Querol, L. Outcome measures and biomarkers in chronic inflammatory demyelinating polyradiculoneuropathy: from research to clinical practice. Expert Review of Neurotherapeutics. 2021; 21(7)DOI:10.1080/14737175.2021.1944104. PMID:34130574. IF:4.287(Q2/4D).